These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16951430)

  • 1. Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis.
    Liu Q; Kriksunov IA; Graeff R; Munshi C; Lee HC; Hao Q
    J Biol Chem; 2006 Oct; 281(43):32861-9. PubMed ID: 16951430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38.
    Liu Q; Kriksunov IA; Graeff R; Lee HC; Hao Q
    J Biol Chem; 2007 Feb; 282(8):5853-61. PubMed ID: 17182614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
    Sauve AA; Munshi C; Lee HC; Schramm VL
    Biochemistry; 1998 Sep; 37(38):13239-49. PubMed ID: 9748331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the mechanism of bovine CD38/NAD+glycohydrolase from the X-ray structures of its Michaelis complex and covalently-trapped intermediates.
    Egea PF; Muller-Steffner H; Kuhn I; Cakir-Kiefer C; Oppenheimer NJ; Stroud RM; Kellenberger E; Schuber F
    PLoS One; 2012; 7(4):e34918. PubMed ID: 22529956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.
    Graeff R; Liu Q; Kriksunov IA; Kotaka M; Oppenheimer N; Hao Q; Lee HC
    J Biol Chem; 2009 Oct; 284(40):27629-36. PubMed ID: 19640843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
    Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
    FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the active site of ADP-ribosyl cyclase.
    Munshi C; Thiel DJ; Mathews II; Aarhus R; Walseth TF; Lee HC
    J Biol Chem; 1999 Oct; 274(43):30770-7. PubMed ID: 10521467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent and noncovalent intermediates of an NAD utilizing enzyme, human CD38.
    Liu Q; Kriksunov IA; Jiang H; Graeff R; Lin H; Lee HC; Hao Q
    Chem Biol; 2008 Oct; 15(10):1068-78. PubMed ID: 18940667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD38 is an authentic NAD(P)+ glycohydrolase.
    Berthelier V; Tixier JM; Muller-Steffner H; Schuber F; Deterre P
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1383-90. PubMed ID: 9494110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inhibitors of CD38: a mammalian cyclic ADP-ribose synthetase.
    Sauve AA; Schramm VL
    Biochemistry; 2002 Jul; 41(26):8455-63. PubMed ID: 12081495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
    Yamamoto-Katayama S; Ariyoshi M; Ishihara K; Hirano T; Jingami H; Morikawa K
    J Mol Biol; 2002 Feb; 316(3):711-23. PubMed ID: 11866528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
    Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
    Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic conformations of the CD38-mediated NAD cyclization captured in a single crystal.
    Zhang H; Graeff R; Chen Z; Zhang L; Zhang L; Lee H; Hao Q
    J Mol Biol; 2011 Jan; 405(4):1070-8. PubMed ID: 21134381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing Aplysia californica adenosine 5'-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors.
    Migaud ME; Pederick RL; Bailey VC; Potter BV
    Biochemistry; 1999 Jul; 38(28):9105-14. PubMed ID: 10413485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the enzymatic active site of CD38 by site-directed mutagenesis.
    Munshi C; Aarhus R; Graeff R; Walseth TF; Levitt D; Lee HC
    J Biol Chem; 2000 Jul; 275(28):21566-71. PubMed ID: 10781610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of bovine spleen NAD+ glycohydrolase in the metabolism of cyclic ADP-ribose-mechanism of the cyclization reaction.
    Muller-Steffner H; Augustin A; Schuber F
    Adv Exp Med Biol; 1997; 419():399-409. PubMed ID: 9193682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase.
    Muller-Steffner HM; Augustin A; Schuber F
    J Biol Chem; 1996 Sep; 271(39):23967-72. PubMed ID: 8798630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.
    Graeff R; Munshi C; Aarhus R; Johns M; Lee HC
    J Biol Chem; 2001 Apr; 276(15):12169-73. PubMed ID: 11278881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
    Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
    J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.
    Cakir-Kiefer C; Muller-Steffner H; Schuber F
    Biochem J; 2000 Jul; 349(Pt 1):203-10. PubMed ID: 10861229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.